Age at onset mixture analysis and systematic comparison in schizophrenia spectrum disorders: Is the onset heterogeneity dependent on heterogeneous diagnosis?

https://doi.org/10.1016/j.schres.2015.03.004Get rights and content

Abstract

A major obstacle to the identification of the neurobiological correlates of schizophrenia is the substantial diagnostic heterogeneity of this disorder. Dividing schizophrenia into “early” and “late” subtypes may reduce heterogeneity and facilitate identification of biomarkers related to this disease. Our objective was to assess the presence of different sub-groups in schizophrenia by age at onset analysis. The participants in this study were 612 unrelated patients with schizophrenia. Admixture analysis was applied in order to identify a model of separate normal distributions of age at onset characterized by different means, variances and population proportions to evaluate the effect of winter birth and ethnicity on early onset schizophrenia. The best-fitting model suggested three subgroups with means and standard deviations of 17.11 ± 2.09, 21.96 ± 3.43 and 30.02 ± 7.1 years, comprising 34.6%, 42.6% and 22.8% of the sample respectively. We considered as predictors of early onset schizophrenia: male gender, winter birth, white ethnicity and positive family history for psychiatric disorders. Earlier onset was significantly associated with male gender. We also compared our age at onset distribution with those published in other studies and we found significant differences with several studies suggesting heterogeneity in age at onset that is likely influenced by diagnostic heterogeneity in applying the DSM-IV criteria. Overall, our study showed that a typical early onset schizophrenia patient is more likely to be a white male with cannabis abuse and positive family history of psychiatric disorders. The heterogeneity in reporting age at onset across different studies suggests the application of more stringent criteria in diagnosing schizophrenia.

Introduction

Among the numerous clinical features of schizophrenia spectrum disorders, age at onset (AAO) is widely recognized as a significant clinical and prognostic factor (Leung and Chue, 2000, Öngür et al., 2009).

Males with schizophrenia have consistently earlier onset, (Leung and Psych, 2000) and other factors such as winter birth (Davies et al., 2003, Torrey et al., 1997), alcohol/drug use (Hambrecht and Häfner, 1996, Dixon, 1999, Chambers et al., 2001), positive family history (Byrne et al., 2002, Mortensen et al., 1999) and ethnicity (Cantor-Graae and Selten, 2005) have also been associated with developing early onset schizophrenia.

Moreover, AAO has been proposed to be the single most important clue to understanding disease etiology (DeLisi, 1992, Tsuang, 2000). There is a growing body of literature demonstrating the clinical interest in early-onset schizophrenia (DeLisi, 1992, Leung and Chue, 2000, Aleman et al., 2003). However, the majority of age cut-off values for early and late onset are arbitrarily chosen and varied across studies (Schürhoff et al., 2004, Köhler et al., 2009, Panariello et al., 2010, De Luca et al., 2012, Vinokur et al., 2014). Therefore, it is expected that there will be significant differences when comparing the AAO distributions across different studies.

In this study, our aim was to obtain empirically derived subgroups of AAO using the admixture analysis. We investigated the effect of ethnicity and winter birth on the AAO in schizophrenia. Based on specific selection criteria, we also provide a review of the studies that have identified sub groups of AAO in schizophrenia. Furthermore, the cut-offs from the reviewed studies were applied to our sample in order to compare the distributions.

Section snippets

Study sample

A cross-sectional study of 612 unrelated patients was conducted. Patients were recruited for participation through the Centre for Addiction and Mental Health in Toronto as part of a study examining the genetics of schizophrenia. The study subjects were referred through the Schizophrenia Clinics at CAMH that assess patients with psychosis of age between 16 and 75. The patients were recruited by two Clinician-Scientists (JLK and VDL) from 1995 to 2012. To meet the criteria for inclusion patients

Demographics

We included 612 participants in our study. The mean age at assessment was 39.8 ± 11.83. There were 427 males and 185 females, 69.2% of the participants were from white Caucasian background and 30.8% were from mixed backgrounds (Table 1). The mean age at assessment was 39.82 ± 11.82 and the mean AAO was 22.125 ± 6.39.

Mclust analysis

The admixture analysis yielded a best fitting model of three Gaussian distributions with unequal variance describing the early, intermediate and late onset groups (Fig. 1). The early

Discussion

The purpose of our study was to assess whether schizophrenia segregates into clinically distinct sub-groups defined by the AAO. This study shows that the observed distribution of AAO in patients with schizophrenia is a combination of three normal distributions, with cutoffs at 19 and 27, identifying these subgroups.

There are several strengths in our study over the previous investigations. Firstly, our sample is the largest one that has been analyzed using the admixture analysis. Secondly, the

Role of funding source

No operating funds were granted to carry on this project.

Contributors

Dr Nowrouzi wrote the paper.

Roy Kahmi contributed to the analysis and manuscript writing.

Jayi Hu performed the literature review.

Michelle Matmari helped in the manuscript preparation.

Dr Kennedy is a clinical collaborator.

Dr De Luca is the senior author who designed the study.

Conflict of interest

Authors have no conflict.

Acknowledgment

Dr De Luca received a CIHR New Investigator Award.

References (43)

Cited by (15)

  • IL-10 (−1082 G/A) polymorphism in Bataknese with schizophrenia

    2024, Journal of Taibah University Medical Sciences
  • Face pareidolia in schizophrenia

    2020, Schizophrenia Research
    Citation Excerpt :

    In SZ, gender differences occur both in neurobiological correlates and clinical presentations: age of onset, symptoms, and disease severity differ strongly between females and males (Angermeyer and Kühn, 1988; Jones, 2013; Nawka et al., 2013). Men have an earlier peak (between 21 and 25 years) in disease onset, whereas women's peak occurs usually 3–5 years later and then again after age of 45 years (Grigoriadis and Seeman, 2002; Nowrouzi et al., 2015). While men show more severe features such as social withdrawal and substance abuse, their female counterparts exhibit more pronounced affective symptoms (Rietschel et al., 2017).

  • Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms

    2017, Frontiers in Neuroendocrinology
    Citation Excerpt :

    Schizophrenia is a psychiatric disease that affects approximately 7 individuals per 1000 (McGrath et al., 2008). The onset of schizophrenia generally occurs in late adolescence and persists for a patient’s lifetime (Nowrouzi et al., 2015; Angermeyer and Kuhn, 1988). The disease is characterized by positive symptoms, negative and affective symptoms, and cognitive deficits.

  • Prognosis of schizophrenia spectrum disorder may not be predetermined during early development - the Northern Finland Birth Cohort 1966

    2016, Schizophrenia Research
    Citation Excerpt :

    The onset of SSD was based on the date of beginning of the registry entry of any psychosis diagnosis (Isohanni et al., 1997; Moilanen et al., 2003). Age at the onset of SSD was classified into < 20, 20–35 and > 35 years based on the earlier studies (Linke et al., 2015; Nowrouzi et al., 2015). Mother's education was classified into 0–8 and 9 years or more, and marital status to “married” and “single/divorced/widowed” and were obtained from the interviews conducted by nurses with the help of questionnaires (Rantakallio, 1969).

View all citing articles on Scopus
1

These two authors contributed equally to this work.

View full text